CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 600,921	$ 136,849	$ 1,647,070	$ 415,477
Cost of revenue	155,138	63,403	869,612	138,180
Gross Profit	445,783	73,446	777,458	277,297
Operating Expenses:
Research and development	481,855	51,820	957,579	221,524
Selling, general, and administrative	3,104,410	832,146	7,320,524	1,719,100
Total Operating Expenses	3,586,265	883,966	8,278,103	1,940,624
Loss From Operations	(3,140,482)	(810,520)	(7,500,645)	(1,663,327)
Other (Expense) Income
Interest expense, net	(758)	(1,284)	(2,389)	(5,004)
Debt redemption costs	0	0	(140,000)
Amortization of debt discount	0	(210,402)	(128,198)	(307,313)
Change in fair value of accrued issuable equity	45,600	9,947	(66,274)	(15,853)
Loss on foreign currency transactions	(292)	0	(292)
Total Other Expenses, net	44,550	(201,739)	(337,153)	(328,170)
Net Loss	(3,095,932)	(1,012,259)	(7,837,798)	(1,991,497)
Deemed dividend to Series D preferred stockholders	0	0	(2,624,326)
Net Loss Attributable to Common Stockholders	$ (3,095,932)	$ (1,012,259)	$ (10,462,124)	$ (1,991,497)
Net Loss Per Share - Basic and Diluted (In dollars per share)	$ (0.03)	$ (0.01)	$ (0.11)	$ (0.02)
Weighted Average Number of Shares Outstanding, Basic and Diluted	99,018,630	82,466,734	93,816,203	82,042,241